Medicare Enrolled

Dr. Rimal B Bera, MD

Psychiatry · Orange, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
UCI MEDICAL CENTER, Orange, CA 92868
7144568978
In practice since 2006 (19 years)
NPI: 1578643656 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bera

Dr. Rimal B Bera is a psychiatry specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bera performed 522 Medicare services across 264 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bera received a total of $191,030 from 30 pharmaceutical and/or device companies across 617 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 27% volume in CA $191,030 industry payments

Medicare Practice Summary

Medicare Utilization ↗
522
Medicare services
Top 27% in CA for psychiatry
264
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
221 $40 $214
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
193 $99 $546
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
45 $31 $315
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $58 $376
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
20 $68 $324
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
16 $116 $865
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$191,030
Total received (2018-2024)
Avg $27,290/year across 7 years
Top 1% in CA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
617
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$126,713 (66.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50,143 (26.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,174 (7.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20,764
2023
$24,642
2022
$17,762
2021
$6,165
2020
$10,862
2019
$36,856
2018
$73,978

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Axsome Therapeutics, Inc.
$15,660
Neurocrine Biosciences, Inc.
$2,795
Janssen Scientific Affairs, LLC
$818
Janssen Pharmaceuticals, Inc
$365
Otsuka Pharmaceutical Development & Commercialization, Inc.
$232
ABBVIE INC.
$223
Alkermes, Inc.
$185
Otsuka America Pharmaceutical, Inc.
$178
E.R. Squibb & Sons, L.L.C.
$130
Teva Pharmaceuticals USA, Inc.
$82
Novo Nordisk Inc
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Biogen, Inc.
$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
Vanda Pharmaceuticals Inc.
$16
Top 3 companies account for 92.8% of 2024 payments
All-time payments by company (2018-2024) ›
Sunovion Pharmaceuticals Inc.
$47,290
Otsuka America Pharmaceutical, Inc.
$36,574
Alkermes, Inc.
$32,797
Teva Pharmaceuticals USA, Inc.
$25,195
Axsome Therapeutics, Inc.
$15,721
Neurocrine Biosciences, Inc.
$13,692
Janssen Pharmaceuticals, Inc
$7,689
Allergan Inc.
$5,076
Sage Therapeutics, Inc.
$2,281
ITI, Inc.
$1,719
Janssen Scientific Affairs, LLC
$818
ABBVIE INC.
$403
Otsuka Pharmaceutical Development & Commercialization, Inc.
$400
AbbVie Inc.
$267
LivaNova USA, Inc.
$254
Indivior Inc.
$151
E.R. Squibb & Sons, L.L.C.
$130
Lundbeck LLC
$113
Vanda Pharmaceuticals Inc.
$94
Avanir Pharmaceuticals, Inc.
$90
Biogen, Inc.
$64
Noven Therapeutics, LLC
$46
Takeda Pharmaceuticals U.S.A., Inc.
$42
Novo Nordisk Inc
$24
JAZZ PHARMACEUTICALS INC.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Allergan, Inc.
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
Eisai Inc.
$15
Travere Therapeutics, Inc.
$1
Top 3 companies account for 61.1% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ARISTADA · AUSTEDO · Aristada 441 mg · Austedo XR · Auvelity · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · FANAPT · HETLIOZ · INGREZZA · INVEGA · INVEGA SUSTENNA · INVEGA TRINZA · LATUDA · LONHALA MAGNAIR · LYBALVI · NUEDEXTA · PERSERIS · REJOYN · REXULTI · SECUADO · SPRAVATO · TRINTELLIX · UZEDY · VNS - Symmetry · VRAYLAR · Wegovy · XYWAV
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for psychiatry in CA.

Looking for a psychiatry specialist in Orange?
Compare psychiatrists in the Orange area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
976
Per 100K population
30.8
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bera is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bera experienced with office visit, established patient (10-19 min)?
Based on Medicare claims data, Dr. Bera performed 221 office visit, established patient (10-19 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bera receive payments from pharmaceutical companies?
Yes. Dr. Bera received a total of $191,030 from 30 companies across 617 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bera's costs compare to other psychiatrists in Orange?
Dr. Bera's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →